COMMUNIQUÉS West-GlobeNewswire

United Health Products Files New Patent Application Method of Forming and Using a Hemostatic Hydrocolloid
08/08/2019
HENDERSON, Nev., Aug. 08, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, today announced that it has filed a patent application [...]
Generex Biotechnology Announces Interview with President & CEO Joe Moscato
08/08/2019
Interview available online on the Wall Street Analyzer website MIRAMAR, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Joe Moscato, the company’s President [...]
Jill Patterson Joins Matrix Medical Network as Chief People Officer
08/08/2019
SCOTTSDALE, Ariz., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Matrix Medical Network, the leading provider of in-home and mobile health clinic assessments and care management, announced that Ms. Jill Patterson has joined the [...]
Idera Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2019 Financial Results
08/08/2019
EXTON, Pa., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of [...]
Vystar Unveils Deproteinized Natural Rubber Latex As Platform for Sustainable Grades of Latex and Solid Rubbers at International Latex Conference
08/08/2019
Creating Bioelastoplast natural rubber materials with improved performance for latex films and solid rubber dynamic applications Incorporating Single Walled Carbon Nano Tubes (SWCNT) at latex stage reduces carbon black [...]
INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
08/08/2019
LA JOLLA, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased [...]
Bellerophon Provides Business Update and Reports Second Quarter 2019 Financial Results
08/08/2019
WARREN, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]
BioCardia Announces Issuance of European Patent for Breakthrough Diagnostic Assay for Patient Selection Prior to Cardiac Cell Therapy Delivery
08/08/2019
SAN CARLOS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the European [...]
Health Catalyst to Announce Second Quarter 2019 Operating Results and Host Conference Call on Thursday, August 22, 2019
08/08/2019
SALT LAKE CITY, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced [...]
Agritek Holdings Inc. to Acquire Apex Solutions, a Licensed Manufacturer, Producer and Distributor of Award-Winning Cannabis Products in California
08/08/2019
LOS ANGELES, Aug. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings Inc. (OTC: AGTK), a fully integrated investor in the legal cannabis sector, today announced that it has entered into a binding letter [...]
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares
08/08/2019
NESS ZIONA, Israel, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (Nasdaq: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
08/08/2019
MENLO PARK, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the opening of patient screening and enrollment for the Phase 3 portion of IMerge to evaluate imetelstat, a first-in [...]
Protech Home Medical Announces Date and Time for Quarterly Conference Call
08/08/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Chimerix Announces Second Quarter 2019 Financial Results and Operational Update
08/08/2019
Pipeline Transformed with Acquisition of Global Rights to Late Stage Oncology Asset (CX-01) with Fast Track and Orphan Drug Designation Phase 3 Trial of CX-01 in Front-Line Acute Myeloid Leukemia Planned to Initiate in [...]
Spectral Medical Provides Corporate Update
08/08/2019
TORONTO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( “Spectral” or the “Company” ) (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion [...]
TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
08/08/2019
TYME Presented Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer NYU Langone and TYME Entered into a Research [...]
Catalyst Biosciences to Host Key Opinion Leader Meeting on Next-Generation Subcutaneous Factor VIIa Marzeptacog Alfa (Activated) in Patients with Bleeding Disorders on August 15
08/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that it will host a Key Opinion Leader (KOL) meeting on next-generation subcutaneous Factor VIIa [...]
Aravive Announces Participation at Wedbush PacGrow Healthcare Conference
08/08/2019
HOUSTON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Aravive Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, today announced [...]
Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock
08/08/2019
EMERYVILLE, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, [...]

Pages